tiprankstipranks
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
US Market
DMAC
Diamedica Therapeutics
RESEARCH TOOLSreports

Diamedica Therapeutics (DMAC) Financial Statements

569 Followers

Diamedica Therapeutics Financial Overview

Diamedica Therapeutics's market cap is currently $333.53M. The company's EPS TTM is $-0.17; its P/E ratio is -11.41; Diamedica Therapeutics is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -34.40M$ -26.68M$ -21.27M$ -14.00M$ -13.65M
EBITDA$ -34.35M$ -26.64M$ -21.24M$ -13.98M$ -13.62M
Net Income$ -32.77M$ -24.44M$ -19.38M$ -13.68M$ -13.59M
Balance Sheet
Cash & Short-Term Investments$ 59.89M$ 44.15M$ 52.90M$ 33.50M$ 45.11M
Total Assets$ 61.37M$ 46.34M$ 54.16M$ 34.40M$ 45.55M
Total Debt$ 240.00K$ 340.00K$ 400.00K$ 469.00K$ 52.00K
Net Debt$ -15.41M$ -2.69M$ -4.14M$ -4.26M$ -4.66M
Total Liabilities$ 5.26M$ 5.63M$ 3.10M$ 2.57M$ 1.53M
Stockholders' Equity$ 56.11M$ 40.72M$ 51.06M$ 31.83M$ 44.02M
Cash Flow
Free Cash Flow$ -29.10M$ -22.10M$ -18.75M$ -11.59M$ -12.27M
Operating Cash Flow$ -29.06M$ -22.08M$ -18.73M$ -11.51M$ -12.25M
Investing Cash Flow$ -2.19M$ 8.56M$ -18.30M$ 11.54M$ -20.54M
Financing Cash Flow$ 43.88M$ 11.99M$ 36.84M$ -6.00K$ 30.09M
Currency in USD

Diamedica Therapeutics Earnings and Revenue History

Income Statement >

Diamedica Therapeutics Debt to Assets

Balance Sheet >

Diamedica Therapeutics Cash Flow

Cash Flow >

Diamedica Therapeutics Forecast EPS vs Actual EPS

Earnings >